• Who we are
    • About us
    • Our values
    • Environmental, social & governance
    • Therapeutic areas
  • What we do
    • Consulting (Acsel Health)
    • HEOR & market access
    • Scientific communications
    • Creative communications
    • Patient engagement
  • Insights
  • News & Events
  • Join us
    • Careers
    • Reasons to join
  • Contact us
  • Menu Menu

Publication Library / Publications

Content validity of the hemophilia device handling and preference assessment questionnaire – A cognitive debrief Study in patients with hemophilia and their caregivers

Introduction

As new treatment options using different modes of administration become available for patients with hemophilia, it is important to assess how patients and caregivers perceive the use of different injection systems.

Aim

This study aimed to evaluate patient comprehension, relevance, and comprehensiveness of the Hemophilia Device Handling and Preference Assessment (HDHPA) instrument among the hemophilia population. Specifically, cognitive interviews were to be conducted to establish evidence of the content validity for the instrument’s use in a handling and preference study.

Methods

This cross-sectional interview study included participants randomly selected from a pen-injector handling and preference study in the USA who had self-administered a ten-item HDHPA questionnaire. Subsequently, semi-structured cognitive interviews were conducted examining HDHPA instrument instructions, items, and response options.

Results

The study sample consisted of 20 participants (50% adult patients, 25% adolescents, and 25% caregivers; 75% male). Most participants (89-100%) demonstrated comprehension of the instructions given. Nearly all participants (94-100%) demonstrated clear comprehension of the ten HDHPA items. All 20 participants stated that the questionnaire was relevant and comprehensive in assessing the pen-injector and comparing it to their current device.

Conclusion

The results of this study showed that the HDHPA items are comprehensible, relevant, and comprehensive, thereby confirming the content validity of this instrument.

Authors N K Rasmussen, S Shah, J-H Tsai, K P McCarrier, E A Hildebrand, M Gonczi, G Ter-Borch, B Berg, J Skov Neergaard
Journal Patient Preference and Adherence
Therapeutic Area Hematology
Center of Excellence Patient-Centered outcomes
Year 2025
Read full article

Services

  • Consulting
  • HEOR & market access
  • Scientific communications
  • Creative communications
  • Patient engagement

Company

  • About Us
  • Our values
  • Environmental, social & governance
  • Our commitment to rare disease
  • Careers
  • Reasons to join
  • News & insights
  • Events
  • Locations & contact

Legal and Governance

  • Terms of use
  • Privacy notice
  • Cookie policy
  • IT security measures
  • Gender pay gap
  • Modern slavery statement
  • Disclosure UK – ABPI
  • Looking for OpenHealth Company?
  • Legal statements & documents
  • Global ethical business conduct code
  • Suppliers
footer-logo-mark
  • Twitter
  • Linkedin
  • Instagram
  • Facebook

© Copyright OPEN Health 2026. All rights reserved. OPEN Health is a registered trademark.

backtotop-arrow
Scroll to top